Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2024-05-17 00:00:00 ET · period of report 2024-05-16 · accession 0001543174-24-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2024-05-16 | ANIP | TANNENBAUM RENEE P | Dir | S - Sale | $63.87 | -2,000 | 18.2K | -10% | -$127.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-16 | S | D | 2,000 | $63.87 | 18,211 | D | — | — |